ZA939707B - Pharmaceutical composition for preventing or treating arteriosclerosis - Google Patents
Pharmaceutical composition for preventing or treating arteriosclerosisInfo
- Publication number
- ZA939707B ZA939707B ZA939707A ZA939707A ZA939707B ZA 939707 B ZA939707 B ZA 939707B ZA 939707 A ZA939707 A ZA 939707A ZA 939707 A ZA939707 A ZA 939707A ZA 939707 B ZA939707 B ZA 939707B
- Authority
- ZA
- South Africa
- Prior art keywords
- preventing
- pharmaceutical composition
- treating arteriosclerosis
- arteriosclerosis
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34747692A JP3465247B2 (ja) | 1992-12-28 | 1992-12-28 | 動脈硬化症の予防および治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA939707B true ZA939707B (en) | 1994-08-29 |
Family
ID=18390484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA939707A ZA939707B (en) | 1992-12-28 | 1993-12-27 | Pharmaceutical composition for preventing or treating arteriosclerosis |
Country Status (12)
Country | Link |
---|---|
US (1) | US5416105A (fr) |
EP (1) | EP0604853A3 (fr) |
JP (1) | JP3465247B2 (fr) |
KR (1) | KR940013503A (fr) |
CN (1) | CN1104888A (fr) |
AU (1) | AU666992B2 (fr) |
CA (1) | CA2112195A1 (fr) |
HU (1) | HUT69398A (fr) |
IL (1) | IL108197A0 (fr) |
NO (1) | NO934832L (fr) |
PL (1) | PL301653A1 (fr) |
ZA (1) | ZA939707B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5631275A (en) * | 1993-12-30 | 1997-05-20 | Hoechst Aktiengesellschaft | Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds |
DE69632402T2 (de) * | 1995-06-30 | 2005-05-19 | Zymogenetics, Inc., Seattle | 4-(2-(n-(-2-carboxamidoindole)aminiethyl)-benzensulfonamide oder sulfonylharnstoffe als pdgf antagoniste |
KR100413745B1 (ko) * | 1995-08-30 | 2004-03-20 | 정규범 | 컨버터스위치의스위칭손실및노이즈저감회로 |
WO2003061643A1 (fr) * | 2002-01-25 | 2003-07-31 | Laboratorios Silanes, S.A. De C.V. | Composition pharmaceutique permettant de surveiller le glucose dans le sang de patients souffrant de diabete de type 2 |
EP1675625B1 (fr) | 2003-09-17 | 2013-02-20 | Board Of Regents, The University Of Texas System | Imagerie de cellules beta pancréatiques spécifique basée sur un mecanisme |
KR100698595B1 (ko) * | 2003-09-29 | 2007-03-21 | 보령제약 주식회사 | 무정형 또는 준결정형 글리메피리드, 이의 제조방법 및 무정형 또는 준결정형 글리메피리드를 포함하는 약학적조성물 |
DE102005034484A1 (de) * | 2005-07-20 | 2007-02-01 | Alfred E. Tiefenbacher Gmbh & Co.Kg | Verfahren zur Herstellung von Glimepirid enthaltenden pharmazeutischen Zusammensetzungen |
MXPA05009633A (es) * | 2005-09-08 | 2007-03-07 | Silanes Sa De Cv Lab | Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada. |
TR201101809A1 (tr) | 2010-12-21 | 2012-07-23 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Vildagliptin ve glimepirid kombinasyonları. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2951135A1 (de) * | 1979-12-19 | 1981-06-25 | Hoechst Ag, 6230 Frankfurt | Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
US4411903A (en) * | 1980-08-11 | 1983-10-25 | American Cyanamid Company | 4-[(Monosubstituted-alkyl)amino]benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents |
CA1339784C (fr) * | 1988-06-23 | 1998-03-31 | Shinya Inoue | Derives de l'acide pyrrolecarboxylique |
-
1992
- 1992-12-28 JP JP34747692A patent/JP3465247B2/ja not_active Expired - Fee Related
-
1993
- 1993-12-17 EP EP9393120376A patent/EP0604853A3/en not_active Withdrawn
- 1993-12-22 CA CA002112195A patent/CA2112195A1/fr not_active Abandoned
- 1993-12-23 US US08/172,145 patent/US5416105A/en not_active Expired - Fee Related
- 1993-12-24 AU AU52706/93A patent/AU666992B2/en not_active Ceased
- 1993-12-27 KR KR1019930029856A patent/KR940013503A/ko not_active Application Discontinuation
- 1993-12-27 ZA ZA939707A patent/ZA939707B/xx unknown
- 1993-12-27 HU HU9303758A patent/HUT69398A/hu unknown
- 1993-12-27 PL PL93301653A patent/PL301653A1/xx unknown
- 1993-12-27 CN CN93121223A patent/CN1104888A/zh active Pending
- 1993-12-27 IL IL10819793A patent/IL108197A0/xx unknown
- 1993-12-27 NO NO934832A patent/NO934832L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP0604853A3 (en) | 1994-08-24 |
PL301653A1 (en) | 1994-07-11 |
HUT69398A (en) | 1995-09-28 |
EP0604853A2 (fr) | 1994-07-06 |
NO934832L (no) | 1994-06-29 |
AU5270693A (en) | 1994-07-07 |
IL108197A0 (en) | 1994-04-12 |
KR940013503A (ko) | 1994-07-15 |
NO934832D0 (no) | 1993-12-27 |
HU9303758D0 (en) | 1994-04-28 |
CA2112195A1 (fr) | 1994-06-29 |
JP3465247B2 (ja) | 2003-11-10 |
JPH06192088A (ja) | 1994-07-12 |
US5416105A (en) | 1995-05-16 |
AU666992B2 (en) | 1996-02-29 |
CN1104888A (zh) | 1995-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0583665A3 (en) | Pharmaceutical composition and method for treating hyperlipidemia and arteriosclerosis | |
GB9208339D0 (en) | Treatment composition | |
GB9319500D0 (en) | Pharmaceutical composition | |
GB2264235B (en) | Composition for nasal treatment | |
GB2272375B (en) | Pharmaceutical composition | |
EP0587047A3 (en) | Gestagenes containing pharmaceutical composition | |
ZA939707B (en) | Pharmaceutical composition for preventing or treating arteriosclerosis | |
GB9221707D0 (en) | Pharmaceutical composition | |
IL106763A0 (en) | Pharmaceutical compositions for treating cancer | |
ZA94155B (en) | Pharmaceutical composition | |
ZA935078B (en) | Pharmaceutical composition | |
IL109758A0 (en) | Pharmaceutical compositions for treating ulcer | |
ZA935931B (en) | Pharmaceutical composition | |
ZA924061B (en) | Pharmaceutical composition | |
ZA931984B (en) | Pharmaceutical composition | |
EP0585208A3 (en) | Skatole inhibiting composition | |
ZA93662B (en) | Sterilising composition | |
GB9206046D0 (en) | Pharmaceutical composition | |
GB9225159D0 (en) | Pharmaceutical composition | |
GB9203897D0 (en) | Pharmaceutical composition | |
GB9203248D0 (en) | Pharmaceutical composition | |
ZA931863B (en) | Pharmaceutical composition | |
GB9209520D0 (en) | Pharmaceutical composition | |
GB9221003D0 (en) | Pharmaceutical composition | |
GB9216596D0 (en) | Pharmaceutical composition |